$USD
$USD
Ranking by Regions
America
Flag of United States United States Flag of Canada Canada Flag of Mexico Mexico Flag of Brazil Brazil Flag of Chile Chile
Europe
Flag of Germany Germany Flag of United Kingdom United Kingdom Flag of France France Flag of Spain Spain Flag of Netherlands Netherlands Flag of Sweden Sweden Flag of Italy Italy Flag of Switzerland Switzerland Flag of Poland Poland Flag of Finland Finland
Asia
Flag of China China Flag of Japan Japan Flag of South Korea South Korea Hong Kong Hong Kong Flag of Singapore Singapore Flag of Indonesia Indonesia Flag of India India Flag of Malaysia Malaysia Taiwan Taiwan Flag of Thailand Thailand
Others
Flag of Australia Australia Flag of New Zealand New Zealand Flag of United States Israel Flag of Saudi Arabia Saudi Arabia Flag of Turkey Turkey Flag of Russia Russia Flag of South Africa South Africa >> All Countries
Ranking by categories
Automakers Airlines Airports Aircraft manufacturers Banks Hotels Pharmaceuticals E-Commerce Healthcare
Courier services Media/Press Alcoholic beverages Beverages Clothing Mining Railways Insurance Real estate
Ports Professional services Food Restaurant chains Software Semiconductors Tobacco Financial services Oil&Gas Electricity
Chemicals Investment Telecommunication Retail Internet Construction Video Game Tech AI >> All Categories
home / United States / Bellerophon Therapeutics
Bellerophon Therapeutics logo

Bellerophon Therapeutics Market Cap

$146,792 Dollars
-50,154 Dollars
BLPH · April 30, 2025
Share price
$0.01
Enterprise Value
$-4.24 M
Change (1-Year)
-62.5%
Global Rank
#9300
Country Rank
#3652
Regions
USA
Market cap

As of April 30, 2025, Bellerophon Therapeutics (BLPH) has a market cap of $146,792 Dollars USD. According to our data, Bellerophon Therapeutics is ranked No.9300 in global market value.

Sector Rank:
Biotech #841 Pharmaceuticals #753
BLPH Market Capitalization Growth
30D Growth:
-78.2%
1 Years Growth:
-62.5%
3 Years Growth:
-99.6%
5 Years Growth:
-99.8%
10 Years Growth:
-100.0%
Total Growth:
-99%

Bellerophon Therapeutics Market Cap CAGR Chart

Similar Companies to Bellerophon Therapeutics

Name Market Cap Market cap difference Regions
United Therapeutics Logo
United Therapeutics
UTHR
$13.51 B
0.000 M
USA icon
USA
Gilead Sciences Logo
Gilead Sciences
GILD
$132.39 B
-0.001 M
USA icon
USA
Pfizer Logo
Pfizer
PFE
$130.73 B
-0.001 M
USA icon
USA
Johnson & Johnson Logo
Johnson & Johnson
JNJ
$375.13 B
0.006 M
USA icon
USA
GlaxoSmithKline Logo
GlaxoSmithKline
GSK
$77.05 B
0.003 M
UK icon
UK
Novartis Logo
Novartis
NVS
$224.23 B
0.160 B
Switzerland icon
Switzerland
Merck Logo
Merck
MRK
$212.01 B
-0.001 M
USA icon
USA
AstraZeneca Logo
AstraZeneca
AZN
$222.30 B
0.004 M
UK icon
UK
Sanofi Logo
Sanofi
SNY
$128.86 B
0.003 M
France icon
France
Amgen Logo
Amgen
AMGN
$152.20 B
0.126 B
USA icon
USA
Bristol-Myers Squibb Logo
Bristol-Myers Squibb
BMY
$98.62 B
0.002 M
USA icon
USA
Eli Lilly Logo
Eli Lilly
LLY
$794.90 B
-0.026 M
USA icon
USA
Biogen Logo
Biogen
BIIB
$17.59 B
0.000 M
USA icon
USA

About Bellerophon Therapeutics Inc.

Name
Bellerophon Therapeutics, Inc.
Website
https://bellerophon.com
Headquarters
Warren,NJ
symbol
BLPH
CURRENCY
USD
country
United States
fullTimeEmployees
18
exchange
OEM
firstTradeDateEpochUtc
2015/02/13
BLPH Market Cap Formula
Market Cap = BLPH Stock Price * BLPH Shares Outstanding
= $0.01 * 12.23 M
= $146,792 Dollars
What is Market Cap?
Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.
Material
wikipedia Share_price outstanding
What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

© 2024 topmarketcap.net